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Abstract 
 
Biodegradable  polymer  nanoparticles  are  considered  for  controlled  drug  delivery  because 
they  are  small  enough  to  diffuse  through  tissues,  target  specific  tissues,  and  penetrate  through 
cell  membranes  to  deliver  drugs  more  locally,  mitigating  side  effects  seen  with  intravenous 
injection.  There  are  still  difficulties  in  producing  polymer  nanoparticles  at  scale  and  in  a  size 
range  (60  nm  to  80  nm  in  diameter)  that  are  large  enough  to  avoid  many  of  the  biological  barriers 
and  yet  small  enough  to  have  reasonable  diffusion  rates  through  tissue.  In  this  work,  the  effects 
of  process  parameters  (Reynolds  number,  amount  of  surfactant,  location  of  surfactant,  quench 
volume,  and  solvent  evaporation  time)  on  the  size  and  polydispersity  index  of  polymer 
nanoparticles  were  investigated  with  the  production  of  nanoparticles  using  solvent  displacement 
method  in  a  confined  impingement  jets  mixer.  Dynamic  light  scattering  was  used  to  determine 
the  size  and  polydispersity  index  of  the  nanoparticles.  Without  surfactant,  it  was  found  that 
Reynolds  number  influenced  the  size  and  polydispersity  index  of  the  nanoparticles  as  the 
particles  aggregated  at  high  flow  rates.  The  location  of  the  surfactant  with  increasing  Reynolds 
number  and  the  concentration  of  surfactant  in  the  aqueous  phase  did  not  have  a  significant  effect 
on  both  the  particle  size  and  polydispersity.  However,  it  was  found  that  a  quench  solution  was 
necessary  to  stabilize  the  nanoparticles,  and  having  a  high  concentration  of  surfactant  in  the 
quench  solution  would  decrease  the  size  of  the  nanoparticles.  Future  work  can  be  done  to 
identify  the  long-term  stability  of  these  nanoparticles,  find  methods  to  purify  them  from  the 
excess  surfactant,  and  conduct  drug  release  studies. 
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Chapter  1.  Introduction 
 
Polymer  nanoparticles  are  widely  researched  in  the  field  of  drug  delivery  because  of  their 
small  size  (less  than  100  nm  in  diameter)  and  their  ability  to  carry  drugs  through  cell  membranes 
and  the  potential  to  target  parts  of  the  body  directly  with  therapy.  Currently,   clinical  drug 
delivery  is  focused  on  Bolus  dosing  where  the  drug  is  administered  within  a  specific  time  frame 
to  obtain  desired  therapeutic  effects  [1].  However,  with  bolus  dosing,  there  is  a  spike  in  drug 
concentration  initially,  and  the  level  of  concentration  is  above  the  therapeutic  concentration 
range  to  extend  the  time  the  patient  remains  in  the  therapeutic  window  of  the  drug   (Figure  1). 
Spiking  the  initial  concentration  can  bring  on  toxic  side  effects.  Additionally,  most  types  of  drugs 
are  delivered  in  such  a  manner  that  the  drug  reaches  many  places  in  the  body  that  are  not  desired, 
resulting  in  unnecessary  consequences  to  the  healthy  surrounding  cells  [2].  
 
 
Figure  1.  Controlled  delivery  vs.  bolus  injection  [1]  
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Nanoparticles  may  provide  an  alternative  to  bolus  injection  that  may  mitigate  many  of 
these  issues.  Controlled  drug  delivery  and  nanoparticles  can  extend  the  time  the  patient  remains 
in  the  therapeutic  window,  as  shown  in  Figure  1.  The  concentration  curve  that  has  a  maximum 
spike  refers  to  the  usage  of  Bolus  dosing  where  the  concentration  of  drug  in  the  bloodstream 
exceeds  the  upper  limit  of  the  therapeutic  level  early  on.  On  the  other  hand,  the  drug  release  with 
nanoparticles  or  another  controlled  drug  delivery  method  can  be  envisioned  with  the 
non-parabolic  line  as  the  concentration  of  drug  released  can  be  administered  to  stay  within  the 
limits  of  the  therapeutic  stage.  Other  applications  of  nanoparticles  could  be  targeting  particular 
cells  that  may  be  affected  by  disease,  thereby  preventing  other  tissues  from  being  harmed  by  the 
therapy  as  is  the  case  with  chemotherapy  [2].  The  pathway  of  drug  delivery  can  be  complicated 
in  the  body.  The  drug  is  often  absorbed  into  the  bloodstream  and  distributed  across  the  body  but 
it  faces  certain  biological  barriers  such  as  intestinal  mucosal  barrier  and  blood-brain  barrier   that 
can  limit  the  penetrability  of  it  [3].  Henceforth,  nanoparticles  are  also  chosen  as  useful  carriers 
since  the  physicochemical  properties  can  be  modified  along  with  the  drug.  
 
In  controlled  release,  the  amount  and  rate  of  drug  eluted  can  be  engineered  during  the 
process  of  making  drug-transporting  materials.  The  chemical  handles  that  can  be  used  to  tailor 
controlled  release  with  polymer  nanoparticles  are  the  polymer  chosen  to  make  the  nanoparticle, 
the  crystallinity  of  the  polymer,  the  degradability  of  the  polymer  bonds,  the  amount  of 
drug-loaded,  the  nanoparticle  size,  and  the  nanoparticle  surface  chemistry  [4].  All  of  these 
features  of  the  polymer  nanoparticles  influence  the  rate  of  drug  release  and  the  final  location  the 
nanoparticles  deliver  their  payload.  
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In  this  project,  nanoparticles  were  made  with  a  confined  impingement  jets  mixer  (IJM).  It 
has  been  shown  that  mixing   with  IJM  allows  rapid  chemical  precipitation  on  the  microscale  in 
addition  to  providing  better  control  over  flow  rates  of  solvents  [5].  The  observed  efficiency  of 
this  micromixing  encourages  more  experimental  work  and  analysis  of  results.  Another  advantage 
of  using  confined  impingement  jets  mixing  is  that  it  can  produce  a  large  amount  of  nanoparticles 
depending  on  the  volumes  of  solvents  used  compared  to  the  amount  of  nanoparticles  that  can  be 
made  with  a  dropwise  addition  method,  which  is  another  synthesis  process.  One  motivation 
behind  this  study  is  to  also  produce  a  high  quantity  of  nanoparticles  to  be  used  as  drug  carriers, 
and  knowing  the  optimum  operating  conditions  of  the  confined  impingement  mixing  setup  would 
support  the  scale-up  endeavors  of  this  process,  which  would  be  helpful  for  future  work.  
 
The  objective  of  this  study  is  to  correlate  confined  impingement  jets  mixing  processing 
parameters  with  the  final  characteristics  of  the  polymer  nanoparticles.  The  goal  is  to  understand 
how  changes  in  the  flow  rate,  location  of  surfactant  (in  water  phase  or  oil  phase),  and  quench 
solution  volume,  during  polymer  nanoparticle  preparation  using  confined  impingement  jets 
mixing,  affect  the  final  nanoparticle  mean  size  and  polydispersity.  By  optimizing  the  process 
parameters  for  particle  size  and  polydispersity  with  the  characterization  of  the  nanoparticles,  an 
efficient  nanoparticle  synthesis  process  can  be  determined. 
 
This  thesis  is  organized  as  follows:  a  literature  review  with  background  information 
required  to  understand  the  concepts  in  the  thesis,  a  materials  and  methods  section  that  provides 
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detailed  descriptions  for  how  to  conduct  the  experiments,  results  and  discussion  section  with  the 
outcomes  and  data  interpretation  from  experimentation  and  finally,  conclusions  and  future  work 
sections.  
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Chapter  2.  Background 
 
2.1  Nanoparticles 
 
With  the  current  drug  delivery  technology  focusing  on  the  development  of  polymer 
nanoparticles,  several  types  of  nanoparticles  with  different  compositions  have  been  researched 
for  controlled  drug  release.  While  there  is  not  a  set  definition  of  nanoparticles,  it  is  agreed  by 
various  scientific  committees  and  government  organizations  that  nanoparticles  refer  to  particles 
that  have  one  dimension  of  100  nm  or  less,  and  for  spherical  particles,  that  dimension  would  be 
the  diameter  [6].  It  is  also  important  to  have  nanoparticles  of  the  desired  size  to  overcome 
biological  barriers  based  on  the  application.  As  of  now,  biodegradable  polymer  nanoparticles 
make  up  the  leading  research  area  in  biomaterials  as  alternatives  for  controlled  drug  delivery 
platforms.  Nanoparticles  are  preferable  over  traditional  drug  delivery  methods  and  the 
advantages  are  as  follows: 
 
- Sustained  release  of  drug  during  transport  and  localization  at  the  site  can  be  achieved  
- Characteristics  of  degradation,  release,  size,  and  surface  can  be  manipulated  depending 
on  the  composition 
- Ligands  can  be  attached  to  the  nanoparticles  to  target  sites  specifically 
- Ease  of  use  for  various  administration  routes  such  as  oral,  nasal,  etc.  
- The  solubility  of  drugs  can  be  monitored  depending  on  the  composition  and 
- Transcytosis  of  drugs  into  intracellular  sites  can  be  accomplished  [4],  [7],  [8]   .  
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Early  studies  on  nanoparticles  focused  on  liposomes  as  drug  carriers  due  to  their  ability  to 
encapsulate  drugs  with  bilayer  shells,  target  sites,  and  reduce  toxic  side-effects  [9].  The  search 
for  carriers  with  better  encapsulation  efficiency  drives  the  research  of  drug  delivery  technology 
to  nanoparticles  that  can  ensure  higher  drug  stability  inside.  In  using  biodegradable  polymer 
nanoparticles  as  drug  delivery  vehicles,  the  drug  molecules  are  entrapped  within  or  adsorbed 
onto  the  surface  of  either  polymer  nanocapsule  or  nanosphere  [10].  Hence,  the  better  the  quality 
of  encapsulation  that  can  be  altered,  the  higher  the  stability  of  the  drug  and  the  better  the  control 
of  degradation.  Meanwhile,  it  is  also  important  to  ensure  that  the  degradation  products  of  the 
polymer  are  biocompatible.  The  degradation  rate  of  the  polymer  is  dependent  on  the  properties 
such  as  glass  transition  temperature,  molecular  weight,  and  degree  of  crystallinity  [11]. 
Therefore,  the  choice  of  polymers  is  a  vital  initial  step  to  make  nanoparticles  where  the 
degradation  rate  can  be  monitored  and  the  degradation  products  are  biocompatible.  
 
2.2  Poly(lactic  acid)  
 
Among  many  common  biodegradable  polymers,  poly(lactic  acid)  (PLA)  is  chosen  for  this 
study  due  to  its  physical  properties.  The  polymer,  shown  in  Figure  2,  can  be  degraded  with  the 
hydrolysis  of  ester  linkage  into  its  lactic  acid  monomers,  which  is  shown  to  be  biocompatible  and 
is  a  metabolite  of  anaerobic  digestion  in  the  body  [12].   The  degree  of  crystallinity  can  also  be 
adjusted  by  manipulating  the  amount  of  each  type  of  stereoisomers;  D  monomers  are  typically 
combined  with  L  monomers,  allowing  the  properties,  such  as  crystallinity  and  degradation  time, 
of  the  polymer  to  be  tailored  accordingly  [13].  As  such,  the  physical  and  mechanical  properties 
of  the  nanoparticle  can  be  controlled  with  polymerization  chemistry[14].   Furthermore,  PLA  can 
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be  easily  copolymerized  with  other  biodegradable  polymers  such  as  poly  (ethylene  glycol)  (PEG) 
and  poly(glycolic  acid)  (PGA)  to  change  structural  properties  [15].  
 
 
Figure  2.  Structure  of  poly(lactic  acid)  
 
2.3  Tetrahydrofuran  
 
The  synthesis  of  nanoparticles  from  polymers  requires  a  versatile  organic  solvent  which 
is  water-miscible  and  can  dissolve  PLA  [16].  Additionally,  to  evaporate  this  solvent  after  the 
formation  of  nanoparticles,  it  needs  to  have  a  low  boiling  point.  Tetrahydrofuran  (THF)  is  a 
colorless  fluid  that  is  polar  enough  for  many  chemical  compounds  to  be  soluble  when  mixed 
with  it  [17].  It  has  a  boiling  point  of  66  ℃,  which  makes  it  easier  to  evaporate  as  well.  Its 
physical  properties  such  as  viscosity  can  also  be  adjusted  by  forming  a  binary  mixture  with 
selected  amounts  of  water  [18].  This  may  be  helpful  in  fine-tuning  the  physicochemical 
properties  of  nanoparticles  that  will  be  developed  later  in  the  synthesis  process  and  it  is  another 
area  where  studies  can  be  done  to  further  understand  the  interactions.  
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2.4  Pluronic  F-127  
 
Surfactants  are  often  employed  in  the  formulation  of  nanoparticles  due  to  their  stabilizing 
effect  on  the  aggregation  of  nanoparticles  [19].  In  this  project,  Poloxamer  407,  also  known  as 
Pluronic  F-127,  is  used  because  of  its  ability  to  disperse  polyesters  and  its  high 
hydrophilic-lipophilic  balance  (HLB)  of  22  [20],  [21].  Having  a  high  HLB  means  that  it  is  more 
water-soluble,  and  this  is  suitable  for  the  project’s  nanoparticle  synthesis  process,  which  involves 
oil  or  organic  solvent  in  water  emulsion  [22].  The  material  itself  is  a  triblock  copolymer  where  a 
block  of  hydrophobic  propylene  oxide  group  exists  between  two  blocks  of  hydrophilic  ethylene 
oxide  groups  with  a  total  of  about  200  units  of  ethylene  oxide  and  60  units  of  propylene  oxide 
(EO 100 -PO 60 -EO 100 ,  a  molecular  weight  of  it  is  12,600  g/mol)  [23].  The  ratio  of  the  number  of  EO 
to  PO  units  is  the  HLB  number[24].  So,  with  oil  in  water  emulsion,  the  propylene  oxide  group 
will  interact  with  the  organic  solvent  when  ethylene  oxide  groups  will  interact  with  water.   As 
the  organic  solvent  interacts  with  the  propylene  oxide  group  of  Pluronic  F-127,  it  will  separate 
from  water,  forming  microstructures  [25].  See  Figure  3  for  the  structure  of  Pluronic  F-127 
micelle  as  particles  formed.  Additionally,  Pluronic  F-127  is  chosen  in  this  project  because  it  has 
been  shown  to  form  mesoporous  silica,  another  type  of  nanoparticles  that  is  considered  for 
therapeutic  drug  delivery  [26].  Another  piece  of  the  ongoing  research  in  the  Vogel  research 
laboratory  is  developing  methods  to  coat  the  PLA  nanoparticles  with  various  inorganic 
molecules.  In  this  study,  by  mixing  Pluronic  F-127,  water,  and  an  organic  solvent,  it  is  expected 
that  the  PLA  dissolved  in  the  organic  solvent  will  associate  with  the  non-polar  block  of  the 
Pluronic  F-127,  form  nanoparticles,  and  become  stabilized.  Pluronic  F-127  then  fulfills  its  role  as 
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a  surfactant  but  the  effect  of  adding  the  Pluronic  F127  in  the  aqueous  phase  or  organic  phase 
prior  to  mixing  is  yet  to  be  determined.  In  this  project,  the  Pluronic  F127  initial  placement  in 
both  organic  and  aqueous  phases  is  explored  and  the  effect  of  the  concentration  in  the  mixture 
was  investigated.  
 
 
Figure  3.  Pluronic  F-127  micelle  with  formation  of  particles 
 
2.5  Synthesis  of  PLA  nanoparticles  
 
Many  methods  can  be  used  to  form  polymer  nanoparticles.  In  general,  there  are  three 
major  synthetic  routes  to  make  polymeric  nanoparticles:  ionic  gelation  of  hydrophilic  polymers, 
polymerization  reaction  from  monomers,  and  dispersion  of  preformed  polymers,  with  the  latter 
two  being  the  common  routes  [27],  [28].  The  polymerization  method  is  often  referred  to  as  a 
“bottom-up”  approach  as  the  monomers  go  through  chemical  reactions  to  grow  a  polymer  that  in 
turn  form  polymeric  nanoparticles.  Another  method  uses  preformed  polymers  that  are  emulsified 
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or  assembled  into  polymer  nanoparticles  using  different  techniques  in  a  “top-down”  approach 
[29].  Choosing  a  synthetic  route  is  dependent  on  the  materials  used,  results  desired,  and  choice  of 
application.  
 
In  this  study,  the  “top-down”  approach  will  be  employed  as  PLA  is  the  biodegradable 
polymer  of  choice  that  is  hydrophobic  [30].  The  common  techniques  with  dispersion  of 
preformed  polymers  method  include  emulsion-diffusion,  emulsion-evaporation,  and 
nanoprecipitation  [29].  It  is  important  to  consider  how  non-polar  or  hydrophobic  the  drug  is 
when  choosing  a  technique  as  these  methods  differ  mostly  on  the  solvents  used  and  respective 
miscibilities.  In  all  techniques,  the  organic  solvent  or  the  oil  phase  will  first  be  added  to  the 
aqueous  phase  to  form  an  emulsion.  For  the  emulsion-diffusion  method,  once  an  emulsion  is 
formed,  a  large  volume  of  aqueous  phase  will  be  introduced  to  disrupt  the  thermodynamic 
equilibrium  of  emulsion,  inducing  polymer  precipitation  [28],  [30].  As  for  emulsion-evaporation, 
after  the  formation  of  emulsion,  the  organic  solvent  has  to  be  evaporated  to  induce  precipitation 
of  nanoparticles  [28],  [30].  With  nanoprecipitation,  also  known  as  the  solvent  displacement 
method,  when  the  organic  solvent  is  mixed  with  the  aqueous  phase,  the  diffusion  of  organic 
solvent  into  aqueous  phase  will  form  a  nanoparticle  suspension  and  the  residual  solvent  is 
evaporated  [31].  The  emulsion-diffusion  typically  requires  large  volumes  of  aqueous  phase  while 
emulsion-evaporation  technique  usually  involves  toxic  solvents  and  high-energy  homogenization 
methods  [32].  Hence,  the  solvent  displacement  method  will  be  used  in  this  study  to  make  PLA 
nanoparticles.  
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2.6  Solvent  Displacement  and  Ouzo  Effect 
 
In  the  solvent  displacement  method,  the  chosen  polymer  is  first  dissolved  into  a 
water-miscible  organic  solvent,  and  when  this  organic  phase  is  mixed  with  an  aqueous  phase, 
that  contains  water  and  surfactant,  the  solvent  rapidly  diffuses  and  forms  a  suspension  [33]. 
Occasionally,  a  quench  solution  is  used  to  help  stabilize  the  nanoparticle  emulsion.  The  quench 
solution  is  just  an  additional  aqueous  phase  that  the  nanoparticle/organic/aqueous  mixture  is 
poured  into.  Quenching  a  mixture  maintains  mild  temperatures  that  allow  high  supersaturation, 
yielding  stabilizing  nanoparticles  [34].  It  is  important  to  know  how  long  the  phases  need  to  be 
mixed  for  all  the  residual  solvent  to  be  evaporated.  With  proper  concentrations,  when  a 
water-miscible  solvent  is  mixed  with  an  aqueous  phase  or  non-solvent,  the  solute  molecules  in 
the  solvent  will  diffuse  out  of  the  bulk  solvent,  forming  nanoparticles  [35].  This  process  is  called 
the  “ouzo”  effect,  and  it  is  named  after  “ouzo”,  a  Greek  alcoholic  drink,  where  there  exists  a 
microemulsion  of  anethole  particles  in  a  mixture  of  water  and  ethanol  [36].  
 
It  is  important  to  have  appropriate  concentrations  of  both  organic  solvent  and  aqueous 
non-solvent  to  obtain  an  “ouzo”  effect.  This  can  be  observed  in  the  ternary  phase  diagram 
(Figure  3),  and  a  stable  emulsion  can  be  produced  spontaneously  in  the  “ouzo”  domain  or 
metastable  region  between  the  binodal  and  spinodal  curves  [37],  [38].  On  the  left-hand  side  of 
the  binodal  curve,  only  one  phase  is  thermodynamically  stable  while  two  phases  can  be 
thermodynamically  stable  on  the  right-hand  side  of  the  spinodal  curve.  Due  to  these  kinetic 
barriers,  it  is  expected  for  the  nanoemulsion  in  the  ouzo  region  to  be  kinetically  stable  [39].  
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Figure  4.  Ternary  Phase  Diagram  [1]  
 
Polymer  nanoparticles  are  formed  by  making  sure  that  the  concentrations  used  are  within 
the  “ouzo”  region.  When  the  organic  and  aqueous  phases  are  mixed,  the  fluctuations  in  the 
surface  tension  between  those  two  phases  create  a  convective  flow  that  causes  supersaturation 
[40].  Supersaturation  then  leads  to  the  nucleation  of  oil  droplets,  to  reduce  saturation,  and 
nanodroplets  are  formed.  Hence,  it  is  important  to  have  proper  concentrations  of  polymer, 
solvent,  and  non-solvent  to  achieve  the  “ouzo”  phenomenon  to  get  nanoparticles  of  the  desired 
size.  Furthermore,  it  is  important  to  note  that  the  addition  of  the  drug  can  shift  the  “ouzo”  region 
[40].  Surfactant  can  be  usually  added  to  stabilize  the  particles  and  prevent  aggregation.  In  this 
work,  the  correlation  between  the  surfactant  in  each  phase  and  the  final  nanoparticle  mean  size 
and  polydispersity  was  explored.  
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2.7  Impingement  Jets  Mixing  
 
Employing  the  solvent  displacement  method,  the  preparation  of  polymer  can  be  carried 
out  with  confined  impingement  jets  mixing  in  a  continuous  process.  The  schematic  and  flow  for 
this  process  can  be  found  in  Figure  5,  and  Confined  Impingement  Jets  Mixer  (IJM)  is  used  for 
micromixing.  The  geometry  of  the  mixer  allows  for  mixing  on  the  millisecond  time  scale  and  it 
has  been  previously  shown  that  block  copolymer  micelle  size  can  be  tuned  by  the  flow  rate 
during  micellization  [41].  The  mixer  allows  nucleation  to  occur  faster  than  the  rate  of  particle 
aggregation.  With  confined  impingement  jets  mixing,  it  is  expected  to  have  more  control  over 
flow  rates  of  streams  and  mixing  time.  By  changing  flow  rates,  the  speeds  of  the  phases  mixing 
can  be  adjusted  and  the  type  of  flow  (laminar  or  turbulent)  can  be  controlled.  Another  advantage 
of  the  IJM  device  is  that  it  allows  two  liquid  streams  to  be  introduced  head-on  at  desired  flow 
rates  in  a  mixing  chamber,  as  kinetic  energy  is  converted  to  the  intensity  of  mixing,  to  form  a 
resulting  mixture  of  nanosuspension  [34].  
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Figure  5.  Schematic  of  Impingement  Jets  Mixing  
 
As  the  flow  rates  of  the  streams  mixing  determine  the  rate  of  mass  transfer,  it  may 
influence  the  size  of  the  nanoparticles  formed  as  well.  Therefore,  as  part  of  this  project,  the  effect 
of  the  flow  rates  of  the  phases  on  the  diameter  of  the  particles  formed  was  studied,  and  different 
flow  rates  of  phases  were  tested  for  experimentation.  Instead  of  flow  rates,  Reynolds  number 
(Re)  was  used  as  a  proxy  in  this  study  to  represent  the  speed  of  mixing.  Reynolds  number  is  a 
dimensionless  number  that  determines  the  flow  regime  and  is  expressed  by  the  equation: 
e  e  R = ∑
n
i = 1
R i = ∑
n
i = 1
��i
ρ v di i i  (1) 
where  refers  to  each  inlet  stream,  n  refers  to  the  total  number  of  inlet  streams,  refers  to  the i ρ
density  of  the  fluid, refers  to  the  velocity  of  the  fluid,  refers  to  the  diameter  of  the  inlet  unit v d
and  𝜇  refers  to  the  viscosity  of  the  fluid  respectively  [33].  As  IJM  has  two  inlet  streams,  Re  of 
the  unit  is  calculated  by  combining  Re’s  of  both  organic  phase  and  aqueous  phase.  So,  if  the  flow 
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rates  of  both  organic  and  aqueous  phases  are  to  increase,  the  Re’s  of  those  phases  will  go  up. 
Since  Re  is  a  function  of  the  density  and  the  viscosity  of  the  fluid,  such  properties  can  be 
adjusted  or  different  solvents  or  non-solvents  can  be  used  to  maintain  a  Re.  Additionally,  Re  is  a 
dimensionless  parameter  that  is  independent  of  the  scale,  and  it  will  be  a  good  measure  to 
explain  the  effects  of  a  single  variable  like  flow  rate  when  other  variables  remain  constant.  
 
2.8  Drug  Release  
 
The  encapsulation  of  drugs  typically  involves  an  oil-water  emulsion  method.  The  drug  is 
first  dissolved  in  a  water-miscible  organic  solvent  and  polymer,  and  this  mixture  will  be 
emulsified  with  an  aqueous  fluid  containing  a  stabilizer  or  surfactant,  followed  by  the 
evaporation  of  organic  solvent  [42].  The  rates  of  the  diffusion  of  the  drug  across  the  polymer 
matrix  and  the  degradation  of  the  polymer  matrix  then  control  the  drug  release  kinetics.  Hence, 
modifying  the  polymer  matrix  properties  such  as  molecular  weight,  hydrophobicity  or 
hydrophilicity,  and  crystallinity,  which  affect  the  degradation  rate  of  the  polymer,  will,  in  turn, 
control  the  drug  release  rate  [43].  
 
2.9  Dynamic  Light  Scattering 
 
To  characterize  the  size  and  polydispersity  of  the  nanoparticles  synthesized,  a  Dynamic 
Light  Scatter  (DLS)  instrument  was  used.  The  size  of  the  nanoparticles  will  be  expressed  in 
terms  of  the  particles’  diameter,  and  the  value  reported  from  DLS  is  z-average,  which  is  defined 
as  the  “harmonic  intensity  average  particle  diameter”  [44].  The  measurement  of  polydispersity 
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explains  whether  the  nanoparticles  in  a  particular  batch  are  homogeneous  or  uniform  in  terms  of 
size,  and  it  is  important  that  the  particles  have  similar  sizes  for  every  production  of  the  same 
operating  conditions.  Since  it  is  an  indicator  of  homogeneity,  the  scale  of  the  polydispersity  value 
ranges  from  0  to  1,  and  a  Polydispersity  Index  (PDI)  should  be  typically  less  than  0.3  for  a 
suspension  to  be  considered  monodisperse  [45].  
 
The  DLS  equipment  itself  emits  light  through  the  nanoparticles  in  suspension,  and 
depending  on  the  intensity  of  the  light  scattered  by  the  particles  inside  when  contacted  with  light, 
the  photon  detector  inside  will  report  the  distribution  profile  of  the  particles  in  that  solution.  The 
fluctuation  of  the  intensity  of  scattered  light  develops  a  function  of  the  exponential  decay  rate  in 
correlation  with  the  diffusion  coefficient,  .  Using  ,  the  hydrodynamic  diameter,  ,  of Dapp Dapp dH
a  particle  can  be  calculated  with  Equation  (2): 
kT 3πμD  dH =   / app (2) 
where  refers  to  the  Boltzmann  constant,  T  refers  to  the  absolute  temperature  and  𝜇  refers  to  the k
viscosity  of  the  solvent  [46].  Advanced  models  of  DLS  equipment  now  just  display  information 
on  the  z-average  of  the  nanoparticles  in  a  suspension  sample  and  the  width  of  the  size 
distribution,  as  specified  by  PDI.  With  the  assumption  of  a  Gaussian  distribution,  PDI  is 
calculated  from  Equation  (3): 
DI  P =   σ2
z­average 2
(3) 
where  refers  to  the  variance  [47].  The  polydispersity  data  can  also  be  utilized  to  determine  the σ2
efficiency  and  reproducibility  of  every  trial  with  the  adjusted  parameter.  
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Chapter  3.  Materials  and  Methods  
 
3.1  Materials  
 
The  information  on  purity  and  suppliers  about  the  materials  used  in  this  study  are 
provided  in  the  following.  Poly  (lactic  acid)  (  ≥  95  %  L-lactide),  also  known  as  Ingeo  3051D, 
with  a  molecular  weight  of  160  kDa  was  acquired  from  Natureworks  LLC.  Pluronic  F-127  and 
Tetrahydrofuran  (THF)  (ACS  reagent  ≥  99.0  %)  were  obtained  from  Sigma-Aldrich.  
 
3.2  Preparation  of  Solutions 
 
The  organic  phase  solution  was  prepared  by  dissolving  polymer  into  a  chosen  solvent.  A 
selected  amount  of  PLA  was  mixed  with  THF  solvent  over  magnetic  stirring  and  heating  to 
obtain  the  organic  phase  solution  for  IJM.  The  ratio  would  be  dependent  on  the  concentration 
required  based  on  the  “ouzo”  region  and  the  resulting  volume  of  the  phase  desired.  For  instance, 
about  1  mg/mL  concentration  of  PLA  in  THF  can  be  obtained  by  adding  300  mg  of  PLA  to  300 
mL  of  THF,  and  this  solution  is  heated  at  about  40  ℃  with  magnetic  stirring  for  2  h  until  the 
polymer  is  fully  dissolved.  A  model  drug  or  dye  could  be  added  if  desired.  
 
Aqueous  phase  for  IJM  was  made  of  Pluronic  F-127  (surfactant),  and  water.  Similar  to 
the  preparation  of  the  organic  phase,  the  surfactant  of  required  amount  was  dissolved  into  a 
non-solvent  over  stirring,  and  the  amount  of  surfactant  added  was  dependent  on  the 
concentration  of  the  aqueous  phase  desired.  For  example,  a  2  wt%  Pluronic  F-127  aqueous 
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solution  is  prepared  by  dissolving  1  g  of  Pluronic  F-127  into  49  mL  of  deionized  water.  The 
sample  did  not  require  heat  during  stirring  to  fully  dissolve  the  surfactant.  
 
3.3  Synthesis:  Impingement  Jets  Mixer  
 
The  synthesis  of  nanoparticles  using  IJM  makes  use  of  equal  volumes  of  both  organic  and 
aqueous  phases.  Having  an  IJM  facilitates  achieving  high  supersaturation  as  it  confines  the 
streams  to  have  equal  and  high  momentum  in  its  chamber  [30].  To  control  the  flow  rates  of  the 
streams  entering  the  IJM,  two  AnaLogix  Bottomless  Solvent  Reservoirs  (BSR)  were  used  on 
each  side  of  IJM,  and  those  units  act  as  pumps  that  adjust  the  speed  of  the  streams  flowing  across 
IJM.  Each  BSR  had  a  speed  setting  of  1  to  99  and  each  designated  speed  setting  corresponds  to  a 
certain  flow  rate.  A  calibration  was  initially  done  to  determine  what  speed  settings  to  use  for 
flow  rates  desired.  Two  measuring  cylinders,  containing  organic  and  aqueous  phases 
respectively,  were  placed  on  different  sides  of  IJM  and  a  beaker  was  placed  directly  under  IJM  to 
collect  the  mixture  of  phases.  This  beaker  contained  an  aqueous  phase  that  was  of  the  same 
amount  of  aqueous  phase  in  mixture  solution  and  it  acted  as  a  quench  solution.  For  the  entire 
set-up,  Tygon  tubing  with  an  OD  of  0.125  in.  and  ID  of  0.0625  in.  was  used  to  connect  the  IJM 
to  the  graduated  cylinders.  
 
Once  the  organic  and  aqueous  phases  were  pumped  into  IJM  with  BSRs  at  desired  flow 
rates,  the  streams  mixed  together  at  the  center  of  the  chamber,  and  the  effluent  dropped  into  the 
collection  beaker  that  contained  a  certain  volume  of  quench  solution.  This  beaker  was 
continuously  stirred  to  facilitate  mixing  and  evaporate  off  residual  organic  solvent  and 
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non-solvent.  Samples  of  nanoparticles  were  then  characterized  to  determine  their  size  and 
polydispersity  with  dynamic  light  scattering  analysis. 
 
For  every  trial,  unless  specified,  a  base  case  of  operating  conditions  were  used.  The 
conditions  for  the  base  case  were  an  aqueous  phase  with  2  wt%  F127  surfactant  dissolved  in 
water.  The  quench  solution  would  also  have  the  aqueous  phase  with  the  same  surfactant 
concentration.  On  the  other  hand,  the  organic  phase  would  consist  of  1  mg/mL  concentration  of 
PLA  in  THF  solvent.  A  typical  run  would  send  about  30  mL  of   each  phase  into  the  IJM,  at  a 
flow  rate  entering  the  IJM  of  120  mL/min  for  each  phase.  
 
3.4  Characterization:  Dynamic  Light  Scattering 
 
Malvern  Zetasizer  NanoRange  was  used  to  determine  the  z-average  (mean  diameter)  and 
polydispersity  of  the  nanoparticles.  To  run  the  analysis,  a  Standard  Operating  Procedure  (SOP) 
was  created  with  the  material  chosen  as  PLA  and  dispersant  chosen  as  water.  The  refractive 
index  and  viscosity  of  water  were  designated  at  1.333  and  1  mPaᐧs  respectively  for  samples  at 
20 ℃.  For  each  trial  of  testing,  a  sample  from  the  nanoparticle  suspension  would  be  placed  in  a 
cuvette  and  the  cuvette  would  be  inserted  into  the  Zetasizer  instrument.  The  report  data 
concerning  z-average  and  polydispersity  were  then  exported.  
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3.5  Freeze-Drying  
 
A  laboratory  freeze-dryer  pump  or  lyophilizer  was  used  to  freeze-dry  the  nanoparticle 
suspension  once  it  had  been  made  with  IJM.  The  samples  were  freeze-dried  to  determine  the 
stability  of  the  nanoparticles’  size  after  a  certain  period  of  time,  and  this  freeze-drying  process 
was  only  carried  out  for  experiments  where  the  resuspension  stability  was  tested.  In  order  to 
freeze-dry  the  nanoparticles,  the  samples  collected  from  IJM  were  first  collected  in  small 
scintillation  vials  or  jars.  These  vials  were  then  frozen  with  liquid  nitrogen  to  prevent  the 
degradation  of  nanoparticles  in  water.  These  frozen  samples  were  then  placed  inside  a  chilling 
container  that  was  connected  to  the  freeze-dryer  pump  that  would  be  on  overnight,  sublimating 
water  and  leaving  only  a  powder  of  particles  the  following  day.  
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Chapter  4.  Results  and  Discussion 
 
4.1  Introduction  
 
The  goal  of  this  thesis  is  to  determine  the  effects  of  the  process  parameters  required  for 
the  production  of  nanoparticles  and  how  the  current  synthesis  procedure  can  be  improved  to 
make  nanoparticles  of  a  desired  size.  Hence,  nanoparticles  were  synthesized  by  adjusting  the 
variables  involved  in  the  making  of  the  particles.  The  variables  or  the  parameters  that  would  be 
optimized  are  detailed  in  the  table  below.  In  each  trial,  the  value  of  one  parameter  was  varied 
while  those  of  the  other  operating  parameters  were  held  constant.  After  each  trial,  the  size  and 
polydispersity  of  the  nanoparticles  were  characterized.  All  the  experiments  were  investigated 
with  1  mg/mL  PLA  in  THF  organic  solvent  and  2  wt%  Pluronic  F-127  aqueous  solutions  at 
120 mL/min  with  a  mixing  time  of  4  h  unless  specified  or  varied  to  determine  the  relevant  effect 
of  the  specified  parameter.  
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Table  1.  Variables  associated  with  the  production  process 
Variable  Justification  
Flow  Rates 
(10  to  200 
mL/min) 
Depending  on  the  flow  rates  of  how  the  solvents  are  mixed,  the  emulsification 
of  nanoparticles  may  be  affected  and  the  size  of  the  nanoparticles  can  change.  
Quench 
Volume 
(0  to  100  mL) 
Quench  solution  contains  more  surfactant  for  better  stabilization  of 
nanoparticles.  It  is  important  to  find  out  how  much  surfactant  is  enough  to 
fully  stabilize  the  nanoparticles  and  whether  the  surfactant  influences  the 
change  in  the  size  of  the  nanoparticles.  
Concentration 
/Location  of 
Surfactant 
(0  to  5  wt%) 
Similar  to  the  justification  in  quench  volume,  the  concentration  of  surfactant 
may  matter  in  its  stabilization  capability.  It  may  also  be  interesting  to 
understand  if  the  role  of  a  surfactant  can  be  better  observed  in  having  it  in  the 
organic  or  aqueous  phase.  
Mixing  time 
(0  to  4.5  h) 
The  nanoparticles  can  become  concentrated  if  the  time  for  evaporation 
extends,  and  whether  this  concentration  can  give  smaller  particles  or  not  will 
be  determined.  
 
For  plots  depicted  in  the  subsequent  sections  (Figure  6  to  Figure  13),  the  solid  bars 
correspond  to  the  values  of  the  particle  diameter  while  the  grey  dots  correspond  to  PDI.  The 
error  bars  represent  the  variations  in  values  for  each  trial  of  certain  operating  conditions.  
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4.2  Effect  of  Reynolds  Number  without  Surfactant 
 
One  parameter  explored  was  the  flow  rates,  expressed  in  terms  of  Reynolds  number,  that 
the  organic  and  aqueous  phases  were  introduced  to  the  IJM  to  mix.  In  this  first  set  of  designs,  no 
surfactant  was  used  in  any  of  the  phases.  The  flow  rates  of  the  solvents  were  varied  from 
30 mL/min  to  120  mL/min  (Re  of  3,630  to  14,500).  The  effects  of  changing  flow  rate  with  no 
surfactant  in  the  aqueous  phase  was  plotted  in  Figure  6. 
 
Figure  6.   PLA  nanoparticle  size  (bars)  and  polydispersity  (points)  without  surfactant  (PLA  + 
THF  for  organic  phase  and  water  for  the  aqueous  phase) 
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As  shown  in  Figure  6,  the  diameter  of  the  particles  increases  from  72  nm  to  1510  nm  with 
increasing  Reynolds  number.  Additionally,  a  high  polydispersity  index  (PDI)  suggested  that  the 
particles  were  less  monodisperse  with  a  broader  size  distribution.  Increasing  the  flow  rate  makes 
the  particle  more  unstable  and  they  are  more  likely  to  aggregate  with  no  surfactant  present. 
Hence,  if  no  surfactant  is  used,  lower  flow  rates  will  produce  smaller  particles.  
 
4.3  Effect  of  Reynolds  Number  with  Surfactant  in  Organic  Phase 
 
Another  parameter  investigated  was  the  location  of  the  surfactant.  To  determine  such 
effect,  2  wt%  Pluronic  F-127  was  dissolved  in  the  organic  phase.  For  this  set  of  experiments,  the 
flow  rates  were  set  at  30  mL/min  to  90  mL/min  (Re  of  3,630  to  10,900),  and  Figure  7  showed  the 
results. 
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Figure  7.  With  surfactant  in  the  organic  phase  (PLA  +  THF  +  F-127  for  organic  phase  and  water 
for  the  aqueous  phase) 
 
There  was  little  change  in  the  diameter  of  the  particles  with  increasing  Reynolds  number 
but  the  size  of  the  particles  seemed  to  decrease  (from  91  nm  to  85  nm)  with  higher  Reynolds 
number.  Furthermore,  the  PDI  was  also  consistent  with  low  variations.  It  was  hypothesized  that 
having  the  surfactant  F-127  was  helpful  in  getting  small  nanoparticles,  and  this  result  approved 
the  tested  hypothesis.  This  result  is  then  due  to  the  expected  fact  that  surfactant  lowers  interfacial 
tension,  reducing  the  pressure  between  the  inside  and  outside  of  the  particle  and  thus,  preventing 
the  stress  of  breaking  up  the  particle  and  forming  aggregates  [48].  So,  overall,  it  was  verified  that 
the  surfactant  played  its  role  of  stabilizing  and  its  effect  was  steadier  when  there  were  higher 
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speeds  of  mixing.  However,  it  is  important  to  note  that  the  change  in  size  is  very  little  and  this 
operating  condition  may  not  impose  strong  significance  in  getting  smaller  nanoparticles.  
 
4.4  Effect  of  Reynolds  Number  with  Surfactant  in  Aqueous  Phase 
 
To  determine  the  effect  of  Reynolds  number  when  the  surfactant  was  used  in  aqueous 
phase,  the  flow  rates  of  the  phases  were  varied  from  10  mL/min  to  200  mL/min  (Re  of  1,210  to 
24,200).  The  results  are  shown  in  Figure  8.  
 
 
Figure  8.  With  surfactant  in  the  aqueous  phase  (PLA  +  THF  for  organic  phase  and  water  +  F-127 
for  the  aqueous  phase) 
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No  visible  trend  could  be  observed  in  Figure  8,  which  described  the  changes  in  particle 
diameter  and  PDI  when  the  Reynold  numbers  became  higher.  Henceforth,  it  could  be  inferred 
that  there  was  no  correlation  between  Reynolds  number  and  the  particle  size  and  polydispersity 
when  the  surfactant  F-127  was  placed  in  an  aqueous  phase.  
 
4.5  Effect  of  Surfactant  Concentration  in  Aqueous  Phase 
 
To  explore  the  stabilization  capabilities  of  the  surfactant,  different  concentrations  of 
Pluronic  F-127  in  water  were  formulated  and  used  in  IJM  with  the  same  concentration  of  PLA  in 
the  THF  organic  phase.  The  amount  of  Pluronic  F-127  added  ranged  from  1  wt%  to  5  wt%  for 
this  set  of  experiments.  Data  of  the  particle  diameter  and  PDI  were  plotted  against  changed 
concentrations  of  surfactant  and  this  could  be  found  in  Figure  9.  
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Figure  9.  With  changing  surfactant  concentration  in  the  aqueous  phase  (PLA  +  THF  for  organic 
phase  and  water  +  F-127  for  the  aqueous  phase) 
 
Based  on  the  results  from  Figure  9,  there  was  no  visible  trend  for  the  change  in  particle 
diameters  with  differences  in  concentration  of  surfactant  Pluronic  F-127  in  the  aqueous  phase. 
The  Critical  Micelle  Concentration  (CMC)  of  Pluronic  F-127  at  25  ℃  is  0.725  wt%,  and  so,  it 
was  expected  that  there  would  not  be  much  effect  since  the  surface  tension  would  stay  constant 
or  be  reduced  at  a  slower  rate  [49].  Although  it  may  seem  that  PDI  increased  with  higher 
surfactant  concentration,  no  significant  conclusion  could  be  drawn  from  the  change  in  PDI  as  the 
values  seemed  to  be  erratic  with  imprecise  ranges  as  the  concentration  of  surfactant  increased. 
Therefore,  it  could  be  interpreted  that  the  concentration  of  surfactant  in  the  aqueous  phase  did 
not  affect  the  resulting  stability  of  the  nanoparticles  in  the  suspension.  
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4.6  Effect  of  Surfactant  Concentration  in  Quench  Solution 
 
Quench  solutions  are  useful  to  better  stabilize  nanoparticles,  and  this  quench  solution 
contains  more  surfactant  to  prevent  aggregation  of  nanoparticles  in  the  suspension.  The 
concentration  of  surfactant  in  the  quench  solution  was  varied  to  determine  its  effect  on  the  final 
particle  size  and  PDI.  The  aqueous  phase  would  still  have  2  wt%  Pluronic  F-127  solution  in 
water  but  the  quench  solution  contained  0  wt%  to  5  wt%  Pluronic  F-127  in  water.  Both  the 
aqueous  phase  and  the  quench  solutions  would  have  the  same  volume.  So,  the  resulting 
suspension  of  each  trial  would  contain  a  1:1:1  ratio  of  organic  phase  to  the  aqueous  phase  to 
quench  solution.  Hence,  the  quench  solution  would  make  up  about  33%  of  the  total  volume  of 
the  resulting  mixture.  An  analysis  of  this  set  of  trials  was  shown  in  Figure  10.  
 
Figure  10.  With  changing  surfactant  concentration  in  the  quench  solution(PLA  +  THF  for 
organic  phase  and  water  +  F-127  for  the  aqueous  phase) 
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As  shown  in  Figure  10,  when  the  concentration  of  Pluronic  F-127  increased  in  the  quench 
solution,  the  size  of  the  nanoparticles  became  larger  (from  61  nm  to  90  nm).  Regardless,  PDI 
was  still  relatively  low,  and  there  existed  narrow  ranges  for  the  dispersion.  Therefore,  these 
results  indicated  that  it  would  be  preferable  to  have  a  lower  concentration  of  surfactant  Pluronic 
F-127  in  the  quench  solution  to  achieve  nanoparticles  of  smaller  size.  This  might  be  due  to  the 
fact  that  higher  concentration  of  surfactant  in  the  quench  solution  would  easily  trap  the  PLA 
dissolved  in  the  organic  solvent,  causing  more  aggregates  in  the  suspension.  
 
4.7  Effect  of  the  Volume  of  Quench  Solution 
 
In  addition  to  understanding  the  impact  of  the  concentration  of  surfactant  in  the  quench 
solution,  experiments  were  conducted  to  determine  the  effect  of  the  volume  of  quench  solution  to 
better  determine  the  appropriate  amount  of  quench  solution  to  use.  The  volume  of  the  quench 
solution  used  were  within  the  range  of  0  mL  to  100  mL  with  the  same  concentration  of  Pluronic 
F-127  in  each  solution,  and  the  results  of  such  variation  can  be  found  in  Figure  11.  
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Figure  11.  With  changing  volume  of  the  quench  solution  (PLA  +  THF  for  organic  phase  and 
water  +  F-127  for  the  aqueous  phase) 
 
According  to  the  data  shown  in  Figure  11,  when  some  quench  solution  was  used,  the 
particle  diameter  decreased  (from  97  nm  to  65  nm).  For  this  set  of  experiments,  the  same  amount 
of  20  mL  of  the  aqueous  phase  was  used  for  every  trial.  While  the  size  of  the  particles  seemed  to 
decrease  with  the  increasing  volume  of  quench  solution,  the  values  of  the  particle  diameter  were 
still  relatively  close.  So,  this  could  be  interpreted  that  using  a  quench  solution  resulted  in 
nanoparticles  with  smaller  sizes  but  the  amount  of  the  solution  required  may  not  have  much 
effect.  Furthermore,  PDI  for  all  trials  were  still  small  with  narrow  ranges,  and  it  could  be  ensured 
that  using  a  quench  solution  is  a  definite  operating  condition.  Therefore,  in  relation  to  the  effect 
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of  the  surfactant  concentration  shown  in  Figure  10,  it  is  deducted  that  20  mL  of  quench  solution 
can  be  used  with  low  concentrations  of  surfactant  to  achieve  smaller  nanoparticles.  
 
4.8  Effect  of  Evaporation  Time  With  and  Without  Surfactant 
 
Once  the  phases  pass  through  IJM  and  form  a  nanoparticle  suspension  together,  the 
suspension  has  to  be  mixed  for  quite  some  time  to  evaporate  off  the  solvents  and  encourage 
nucleation.  It  is  critical  to  know  the  necessary  evaporation  time  as  the  process  time  can  be 
associated  with  many  factors  such  as  costs  and  the  number  of  times  trials  can  run  in  a  certain 
amount  of  period.  So,  the  evaporation  time  was  investigated  for  systems  with  and  without  the 
surfactant  Pluronic  F-127  and  DLS  data  was  collected  every  30  min.  for  each  system.  Results 
were  plotted  in  Figures  12  and  13.  
 
Figure  12.  Without  surfactant  in  the  entire  system  (PLA  +  THF  for  organic  phase  and  water  for 
the  aqueous  phase) 
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Figure  13.  With  surfactant  in  the  aqueous  phase  (PLA  +  THF  for  organic  phase  and  water  + 
F-127  for  the  aqueous  phase) 
 
Both  Figures  12  and  13  indicated  a  strong  finding  that  the  process  required  quite  a  long 
evaporation  time  to  stabilize  the  nanoparticles  and  drastic  change  in  size  could  be  observed 
within  the  first  30  minutes.  A  total  time  of  about  4  h  seemed  to  be  the  appropriate  amount  to 
evaporate  off  the  solvents  and  obtain  nanoparticles  of  the  smallest  sizes  in  each  trial.  While  there 
seemed  to  be  particles  of  lower  sizes  without  surfactant  in  the  first  few  hours,  the  PDI  values 
were  quite  large  and  instability  could  be  observed  over  the  mixing  time.  On  the  other  hand,  when 
surfactant  was  used  in  the  aqueous  phase,  PDI  values  were  consistent  after  every  30  min.  and  the 
particles  were  thought  to  be  stabilizing  over  time.  As  both  experiments  with  and  without 
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Pluronic  F-127  surfactant  after  4  h  of  mixing  time  gave  nanoparticles  of  smaller  size,  the 
resuspension  abilities  between  samples  with  and  without  the  surfactant  after  freeze-drying  was 
compared.  
 
4.9  Effect  of  Surfactant  for  Resuspension  after  Freeze-Drying  
 
Earlier  in  this  thesis,  it  was  shown  that  it  was  possible  to  obtain  nanoparticles  of  small 
sizes  without  the  surfactant  at  Re  of  3,630.  However,  over  the  results  of  many  experiments,  it 
was  observed  that  the  polymer  nanoparticles  tended  to  aggregate  over  time,  and  it  was 
hypothesized  that  surfactant  can  be  useful  to  prevent  such  aggregation  beyond  achieving  smaller 
nanoparticles  when  the  suspensions  were  first  made.  Hence,  the  resuspension  stabilities  of  the 
samples  with  and  without  the  surfactant  were  investigated.  To  do  this,  once  the  suspensions  were 
made,  the  samples  were  freeze-dried  for  approximately  a  day.  These  samples  were  then  diluted 
with  deionized  water  and  vortexed  to  resuspend  the  particles,  and  DLS  was  used  to  determine  the 
size  of  the  nanoparticles  in  those  samples.  Table  2  includes  information  on  the  diameter  of  the 
nanoparticles  for  the  samples.  As  expressed  in  the  table,  the  size  of  the  particles  only  increased  to 
a  certain  relatively  smaller  size  with  the  surfactant  but  when  there  was  no  surfactant  used,  the 
nanoparticles  aggregated  to  form  micron-sized  particles  that  had  diameters  of  over  1000  nm. 
These  results  suggest  that  surfactant  is  indeed  necessary  to  stabilize  the  nanoparticles  for 
long-term  shelf  life  and  allow  for  resuspension.  Since  the  particles  aggregated  to  some  extent 
even  with  Pluronic  F-127,  it  shows  a  need  to  find  better  ways  to  stabilize  nanoparticles,  and  the 
resulting  mixture  suspension  from  IJM  should  be  processed  as  soon  as  possible  for  further  uses 
or  steps  in  the  drug  delivery  development  process.  
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Table  2.  Resuspension  stabilities  with  and  without  surfactant  F-127 
 Average  nanoparticle 
diameter  without  F-127  (nm) 
Average  nanoparticle 
diameter  with  F127  (nm) 
Before 
freeze-drying  and 
resuspension 
96.92 80.78 
After  freeze-drying 
and  resuspension 
1345 392.0 
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Chapter  5.  Conclusions  and  Future  Work 
 
5.1  Conclusions 
 
● PLA  nanoparticles  can  be  synthesized  using  the  solvent  displacement  method  in  confined 
impingement  jets  mixer  (IJM)  with  THF  and  Pluronic  F-127  surfactant.  
● When  a  surfactant  was  not  used,  the  Reynolds  number  seemed  to  influence  the  size  of  the 
nanoparticles  as  the  particles  became  increasingly  unstable  and  aggregated  at  high  flow 
rates.  This  also  caused  the  PDI  of  the  suspension  to  be  high. 
● When  the  surfactant  is  used  in  the  either  organic  or  aqueous  phase,  Reynolds  number  did 
not  have  a  significant  effect  on  both  particle  size  and  PDI.  
● It  was  shown  that  Pluronic  F-127  had  a  stabilizing  effect  as  it  reduced  the  interfacial 
tension  and  prevented  aggregation  of  particles. 
● While  the  concentration  of  surfactant  above  the  CMC  in  aqueous  phase  affected  neither 
particle  size  nor  PDI,  increasing  concentration  of  surfactant  in  the  quench  solution 
decreased  the  size  of  the  nanoparticles. 
● Regardless  of  the  volume  of  the  quench  solution  used,  it  was  shown  that  the  quench 
solution  was  necessary  to  stabilize  the  PLA  nanoparticles. 
● Evaporating  THF  out  of  nanoparticle  suspension  for  about  4  h  was  found  to  be  effective 
to  obtain  smaller  nanoparticles. 
● Using  Pluronic  F-127  surfactant  improved  the  resuspension  stability  of  PLA 
nanoparticles  in  deionized  water  after  one  day.  
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5.2  Future  Work  
 
The  application  for  these  particles  in  the  pharmaceutical  industry  is  size-dependent  and 
relies  on  purified  particles.  Hence,  filtration  or  relevant  purification  methods  should  be  carried 
out  to  select  and  purify  polylactic  acid  (PLA)  polymer  nanoparticles  from  excess  surfactant.  The 
Vogel  Research  Group  is  studying  the  use  of  Tangential  Filtration  Unit  (TFU),  that  consists  of 
membranes  of  defined  pore  size,  as  a  means  to  achieve  such  a  goal.  
 
This  project  encompassed  the  effects  of  varying  the  production  parameters  to  help 
identify  the  optimum  conditions  for  making  nanoparticles  of  desired  size  and  polydispersity.  The 
Vogel  Research  Group  has  independent  simultaneous  projects  on  synthesizing  PLA  nanoparticles 
and  hydrogels,  and  the  subsequent  goal  would  be  to  merge  these  projects  to  identify  an  effective 
drug  delivery  method  where  particles  will  be  loaded  into  hydrogels.  Hydrogels  can  be  used  to 
encapsulate  the  drugs  loaded  nanoparticles  to  travel  within  the  body  and  release  them  at  the 
desired  location  over  a  desired  amount  of  time.  Model  drug  release  studies  can  then  be  carried 
out.  Having  an  efficient  nanoparticle  synthesis  process  with  optimized  process  parameters,  there 
is  an  advancement  for  the  related  projects  in  the  Vogel  Research  Group  for  creating  a  new  drug 
delivery  method  and  the  research  field  where  it  is  important  to  identify  the  most  important 
parameters  for  the  production  of  nanoparticles.  
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